Macrophage Function and the Role of GSK3

被引:24
|
作者
Patel, Sarvatit [1 ,2 ]
Werstuck, Geoff H. [1 ,2 ,3 ]
机构
[1] Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L9L 2X2, Canada
[2] McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada
[3] McMaster Univ, Dept Med, 1280 Main St W, Hamilton, ON L8S 4L8, Canada
关键词
macrophage function; glycogen synthase kinase (GSK)-3; molecular mechanisms; inflammatory response; atherosclerosis; GLYCOGEN-SYNTHASE KINASE-3-BETA; PI3K/AKT/GSK-3-BETA SIGNALING PATHWAY; SKELETAL-MUSCLE; ATTENUATES ATHEROSCLEROSIS; INDUCED APOPTOSIS; DOWN-REGULATION; KINASE; ACTIVATION; INHIBITION; CELLS;
D O I
10.3390/ijms22042206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages are present in nearly all vertebrate tissues, where they respond to a complex variety of regulatory signals to coordinate immune functions involved in tissue development, metabolism, homeostasis, and repair. Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed protein kinase that plays important roles in multiple pathways involved in cell metabolism. Dysregulation of GSK3 has been implicated in several prevalent metabolic disorders, and recent findings have highlighted the importance of GSK3 activity in the regulation of macrophages, especially with respect to the initiation of specific pathologies. This makes GSK3 a potential therapeutic target for the development of novel drugs to modulate immunometabolic responses. Here, we summarize recent findings that have contributed to our understanding of how GSK3 regulates macrophage function, and we discuss the role of GSK3 in the development of metabolic disorders and diseases.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [31] The role of pericyte GSK3β in renal aging and disease
    Chen, Yu-En
    Pan, Szu-Yu
    Chou, Yu-Hsiang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (08) : 828 - 829
  • [32] Role of GSK3 activity in optic nerve regeneration
    Fischer, D.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [34] GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
    Rios, Israel
    Lopez-Navarro, Baltasar
    Torres-Torresano, Monica
    Palacios, Blanca Soler
    Simon-Fuentes, Miriam
    Dominguez-Soto, Angeles
    Muller, Ittai B.
    Jansen, Gerrit
    Corbi, Angel L.
    Puig-Kroger, Amaya
    JOURNAL OF INNATE IMMUNITY, 2023, 15 (01) : 283 - 296
  • [35] GSK3β activity modifies the localization and function of presenilin 1
    Uemura, Kengo
    Kuzuya, Akira
    Shimozono, Yoshiharu
    Aoyagi, Nobuhisa
    Ando, Koichi
    Shimohama, Shun
    Kinoshita, Ayae
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (21) : 15823 - 15832
  • [36] Simultaneous inhibition of GSK3α and GSK3β using hairpin siRNA expression vectors
    Yu, JY
    Taylor, J
    DeRuiter, SL
    Vojtek, AB
    Turner, DL
    MOLECULAR THERAPY, 2003, 7 (02) : 228 - 236
  • [37] Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
    Gao, Fei
    Al-Azayzih, Ahmad
    Somanath, Payaningal R.
    ONCOTARGET, 2015, 6 (08) : 5947 - 5962
  • [38] Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors
    Wadhwa, Pankaj
    Jain, Priti
    Jadhav, Hemant R.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (17) : 1522 - 1534
  • [39] XIAP associates with GSK3 and inhibits the promotion of intrinsic apoptotic signaling by GSK3
    Sun, Mianen
    Meares, Gordon
    Song, Ling
    Jope, Richard S.
    CELLULAR SIGNALLING, 2009, 21 (12) : 1857 - 1865
  • [40] GSK3 as a pathogenic kinase in tauopathy and the use of GSK3 inhibitors such as Lithium as a therapeutic
    Duff, Karen
    Planel, Emmanuel
    Noble, Wendy
    MOVEMENT DISORDERS, 2008, 23 (08) : 1197 - 1197